Advertisement

Methylome of human senescent hematopoietic progenitors

  • Stephen Capone
  • Anthony R. Colombo
  • Benjamin K. Johnson
  • Tim J. TricheJr.
  • Giridharan Ramsingh
Open Access
Research

Abstract

Senescence, a state of permanent cell cycle arrest, can be induced by DNA damage. This process, which was initially described in fibroblasts, is now recognized to occur in stem cells. It has been well characterized in cell lines, but there is currently very limited data available on human senescence in vivo. We recently reported that the expression of transposable elements (TE), including endogenous retroviruses, was up-regulated along with inflammatory genes in human senescent hematopoietic stem and progenitor cells (HSPCs) in vivo. The mechanism of regulation of TE expression is not completely understood, but changes in DNA methylation and chromatin modifications are known to alter their expression. In order to elucidate the molecular mechanisms for TE up-regulation after senescence of HSPCs, we employed whole-genome bisulfite sequencing in paired senescent and active human HSPCs in vivo from healthy subjects. We found that the senescent HSPCs exhibited hypomethylated regions in the genome, which were enriched for TEs. This is the first report characterizing the methylome of senescent human HSPCs.

Keywords

Senescence Hematopoietic stem and progenitor cells Inflammation Transposable elements Endogenous retroviruses Whole genome bisulfite sequencing Methylation CEBPβ Transcriptome 

Introduction

Aging is characterized by a progressive loss of organ function. The complex cellular process of stem cell aging likely contributes to the aging phenotype [1, 2, 3]. Cellular senescence, defined as a state of permanent cell cycle arrest, plays a distinct and important role in aging [4, 5, 6]. A plethora of stresses, such as telomere shortening, mitochondrial dysfunction, oxidative stress, DNA damage, and expression of oncogenes, can provoke senescence [7].

While the phenomenon of senescence was originally described in fibroblasts, it has now been shown to occur in stem and progenitor cells, with senescent hematopoietic, hepatic, endothelial, and skeletal muscle progenitor populations identified [8, 9, 10, 11, 12, 13, 14, 15]. However, comprehensive molecular features of human senescent cells in vivo have not been well investigated. We recently identified and isolated circulating senescent HSPCs from healthy human subjects and showed that their transcriptome had elevated expression of transposable elements (TEs) [16].

Repetitive sequences comprise two-thirds of the human genome, out of which 50% are TEs [17]. TEs have been recognized to play an important role in the dynamics of species evolution by creating genetic diversity and their expression has also been shown to be up-regulated in both aging and senescence [18, 19]. We recently showed that the expression of TEs is suppressed in leukemic stem cells [20] which also appears to prime the cells for immune-mediated clearance via activation of the interferon pathway [21, 22, 23]. Hence, tight regulation of TEs appears crucial for homeostasis.

Recent studies have begun to explore the mechanisms regulating the expression of TEs. Epigenetic mechanisms, specifically DNA methylation and chromatin modifications, tightly regulate the expression of TEs [24, 25, 26]. DNA hypomethylation has been shown to activate TEs, which can subsequently lead to genomic instability, resulting in tumorigenesis [27, 28] or cellular clearance by the immune system [21, 22]. These studies were primarily performed using cell lines in vitro. We wanted to examine whether the TE induction observed in human senescent HSPCs in vivo was due to a similar loss of DNA methylation. For this, we performed whole-genome bisulfite sequencing (WGBS) on senescent and active human HSPCs in vivo and characterized their methylome.

Materials and methods

Human in vivo senescent CD34+ HSPC isolation

Human in vivo senescent CD34+ HSPC were obtained and isolated from healthy subjects as previously described [16]. Briefly, cells were drained from leukocyte reduction system cones collected from healthy platelet donors. HSPCs were enriched using the RosetteSep human progenitor enrichment cocktail (StemCell Technologies). Following a 20-min incubation with the enrichment cocktail at room temperature, mononuclear cells were isolated by density gradient centrifugation using Ficoll-Paque premium (GE Healthcare). The mononuclear cells were suspended in IMDM containing 100 nM bafilomycin A1 for 1 h at 37 °C, followed by incubation with C12FDG at 37 °C for 90 min. Then, the cells were washed with sorting buffer and stained with PE-conjugated anti-CD34, PE-Cy7-conjugated anti-CD38, and APC-conjugated anti-CD45 (eBiosciences) and subjected to fluorescence-activated cell sorting (FACS) (BD FACS Aria III). Dead cells were excluded based on propidium iodide staining. Samples were sorted for CD34+ and CD45dim+ cells to identify HSPCs and then gated for C12FDG staining for senescence-associated beta-galatosidase (SA-βgal) expression [29]. To identify CD38+ and CD38− populations, we used PE-Cy7-conjugated anti-CD38 antibody (eBiosciences). The protocol was approved by the Institutional Review Board (Protocol # IRB-HS-12-00693).

WGBS and methylation analysis

Libraries for whole-genome bisulfite sequencing were generated from 5 ng of purified DNA from paired senescent and active CD34+ cells from 3 healthy human donors (33, 45, and 53 years of age) using the NuGen Ovation Ultralow MethylSeq Kit following the manufacturer’s protocol, for a total of 6 individual libraries. Samples were not pooled prior to library generation. Reads were aligned using Biscuit and Metilene was used for calling of differentially methylated regions. Motif analysis of DMRs was conducted using the PWMEnrich package with Hocomoco and Factorbook motif databases provided in the motifbreakR package [30].

Chromatin conformation inference from WGBS data

Reads were aligned using biscuit and post-processed using biscuiteer [31] prior to compartment inference. Briefly, observed CpG loci were restricted to “open sea” regions and smoothed using a Dirichlet smoothing approach. Loci that had less than 3× coverage were set to values of NA and any locus that had greater than 50% NAs were removed from the dataset. Remaining NAs were imputed using k-nearest neighbors [32, 33]. Chromatin confirmation inference was performed as described previously [34] and implemented in compartmap [35].

Results

Senescent human HSPCs isolated from peripheral blood of healthy subjects

In order to assess if epigenetic alterations such as changes in DNA methylation contributed to increased expression of TEs in senescent HSPCs, we subjected paired senescent and active HSPCs from 3 healthy humans to WGBS. We employed a modified FACS protocol [16] to identify and isolate senescent and non-senescent HSPCs (CD34+ CD45dim+ cells) from peripheral blood of healthy platelet donors. Senescence-associated β-galactosidase (SA-β-gal) was used as a senescence marker [12, 13, 14, 15, 36, 37] to identify and isolate circulating senescent HSPCs as previously described [16]. Using this technique, we isolated between 2800 and 4800 senescent HSPCs and 250,000 to 360,000 non-senescent HSPCs from each of our three individual donors. All samples were standardized to an input of 5 ng prior to WGBS library generation.

Senescent human HSPCs display focal loss of DNA methylation

WGBS yielded 7.5× genome coverage. Using the 2-dimensional Komogorov-Smirnov approach implemented in Metilene with cutoffs of 10% minimum difference, 10 CpGs and 10% FDR, we identified 61 differentially methylated regions (DMRs) in senescent vs. active HSPCs, of which 51 were hypo-methylated (hypoDMRs) and 10 hyper-methylated (hyperDMRs) (Additional file 1: Table S1). Multi-resolution chromatin conformation inference for non-senescent and senescent HSPCs revealed representative genome-wide changes in open/closed compartments between cell types (Fig. 1). DNA methylation changes in the senescent cells were focal rather than global (Figs. 1 and 2). By mapping the hypoDMRs to chromatin states using ChIP-seq data of primary human CD34+ cells, we found the majority of DMRs to overlap with transcriptional enhancers (Fig. 3b). CCAAT/enhancer binding proteins (CEBPA/B/G) were the dominant motif (8/10 top hits) in hypoDMRs (Fig. 3b). CBFA2T2, TIMM44, and Myc-associated factor X were among the top hits in hyper DMRs (Fig. 3b).
Fig. 1

Multiresolution chromatin confirmation. Multi-resolution chromatin conformation inference for non-senescent (red/gray) and senescent (yellow/gray) HSPCs across chromosome 6 reveals representative genome-wide changes in open/closed compartments between cell types. The 50 kb resolution shows widespread focal chromatin accessibility across chromosome 6, encompassing regions rich in TEs. Open chromatin (negative eigenvalues); closed chromatin (positive eigenvalues)

Fig. 2

Whole genome bisulfite sequencing of senescent HSPCs. Focal loss of DNA methylation observed in senescent HSPCs obtained through whole genome bisulfite sequencing. Senescent population (CD34+ SA-β-Gal –) is represented in orange, with non-senescent population (CD34+ SA-β-Gal +) shown in blue. This shows alterations in methylation along a representative segment of chromosome 6, with focal hypomethylation of gene promoter regions of HLA-DRB5 and HLA-DRB6

Fig. 3

Characterization of the differentially methylated regions in senescent HSPCs. a Mapping of hypo- and hyperDMRs to chromatin states of CD34+ cells. Hypomethlation is spread diversely throughout different regions of the genome, with promoter and enhancer regions showing a propensity for hypomethylation. b Motif enrichment analysis of statistically significantly DMRs shows high concordance of both hypermethylated and hypomethylated regions of the genome, with selected targets noted. Hypomethylated regions show a clustering of CEBP enhancer regions

Enrichment of repetitive elements in the hypoDMRs of senescent HSPCS

Next we examined whether the hypoDMRs correlated with the repeat regions in the genome. Interestingly, all of the hypoDMRs (51/51) but only 4/10 of the hyperDMRs overlapped with repeat elements (Fig. 4, Additional file 2: Figure S1 and Additional file 3: Table S2). Based on the observation that ~ 50% of the genome is repetitive and that an overlap may equally likely affect hyper- and hypo-DMRs, Fisher’s Exact test showed a significantly increased occurrence of repeat elements in the hypoDMRs (P < 10−6). This led us to conclude that senescent HSPCs display focal loss of DNA methylation in the repetitive DNA-containing DMRs.
Fig. 4

Regions with loss of methylation overlapped with the repeat elements in the genome. Senescent population (CD34+ SA-β-Gal –) is represented in orange, with non-senescent population (CD34+ SA-β-Gal +) shown in blue in this representative region of chromosome 6 (158507720:158508419) and region of hypomethylation overlapping with transposable element

Discussion

This is the first study to perform WGBS in human senescent cells in vivo. Previous WGBS studies on replicative senescence in cell lines showed global genome-wide loss of methylation [38]. Cruickshanks et al. [38] suggest that methylation signatures in senescence are fixed once the cell cycle ceases, and are therefore a reflection of previous epigenetic events. Our study using in vivo senescent HSPCs showed only focal loss of methylation, suggesting the mode of senescence in in vitro replicative senescent cells and in human in vivo senescent HSPCs were likely different. DNA methylation changes that accumulate over time during cell passage in vitro may be a reason for this difference. We speculate that the senescence in HSPCs was likely due to a stress response, such as oxidative stress. Our study showed that the hypoDMR regions were enriched for both TEs and enhancer marks. This finding is consistent with prior studies showing hypomethylated TE-rich genomic regions containing enhancer marks [25, 26]. TEs are known to play a significant role in regulation of gene expression [39]. The physical proximity of the TE and enhancers regions is possibly a result of co-evolution. Future studies on how TEs cooperate with the nearby enhancer regions to modulate gene expression are warranted.

Several chromatin modifiers including CTCF, BORIS, DDM1, LSH1, KDM1A and transcription factors like p53, SIRT1, FOXA1, SP1 have been shown to maintain the TEs in a dormant state [40, 41, 42]. We found that CEBP binding sequences were enriched in the focally hypomethylated regions of the genome. Previous studies have shown methylation-specific increases in DNA binding affinity for CEBPβ [43, 44, 45, 46, 47], which also plays a significant role in regulating senescence associated secretory phenotype (SASP), an inflammatory phenotype known to occur with senescence induction [43, 44, 45, 46, 47]. It is possible that CEBPβ regulates TE expression in a methylation-specific manner, a mechanism that needs to be explored.

The major limitation of this study is the low sequencing depth, which may lead to the relatively low number of DMRs identified. We hypothesize that future deeper sequencing with high coverage will help elucidate additional DMRs, helping unlock additional upregulation of TEs. Because of the low depth of sequencing, it is possible that not all DMRs met the stringent requirements for our study, yet are still contributing to the overall upregulation of TEs. It is also important to note that hypomethylation may not be the only factor contributing to the upregulation of TEs. Histone modifications are a major mechanism that may also play a role in this overexpression of TEs and should be further investigated. These changes can be evidenced by the widespread focal opening of chromatin not solely accounted for by DMRs. High resolution mapping of chromosome 6 shows increasing numbers of focal open regions in senescent HSPCs when compared to non-senescent. This is consistent with a widespread focal opening of chromatin, which could lead to increased TE expression.

Recent studies have elucidated the role of TEs in various pathologies, such as motor neuron disease, autoimmune diseases and cancers [48, 49, 50, 51, 52, 53, 54, 55], motivating a deeper understanding of the dysregulation mechanisms of TEs. Understanding the regulation of TE expression could enable better understanding of the pathophysiology of the disease, facilitating the development of better treatment options.

Dysregulation of TEs has also been implicated in accelerated aging in mouse models of senescence. Loss of methylation in TE-rich regions of the genome has been shown in both mice and human aging [56, 57, 58]. Recent studies have shown that hypomethylating agents in cell lines induce the expression of TEs, which causes activation of the viral recognition pathway and inflammatory gene expression [21, 22]. We speculate that similar mechanisms may underlie the inflammatory phenotype seen in senescence, warranting further mechanistic studies in senescence exploring the link between hypomethylation, activation of TE expression and immune activation.

Notes

Authors’ contributions

SC did isolation of human HSPCs and performed the WGBS and wrote the paper, AC and TT did the WGBS analysis, and GR and TT designed the research, analyzed the data, and wrote the paper. All authors read and approved the final manuscript.

Acknowledgements

This project was funded by grants from Leukemia Lymphoma Society-Quest for Cures #0863-15, STOP Cancer, Tower Cancer Research Foundation, and the Keck School of Medicine of the University of Southern California, Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases University of Southern California. Technical support was provided by the Clinical Microarray Core at the University of California Los Angeles and University of Southern California Epigenome Center.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The whole genome bisulfite data will be deposited in small reads archives.

Consent for publication

Obtained from all authors.

Ethics approval and consent to participate

The protocol was approved by the Institutional Review Board (Protocol # IRB-HS-12-00693).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

40164_2018_123_MOESM1_ESM.xlsx (11 kb)
Additional file 1. Compiled list of differentially methylated regions in senescent vs. active HSPCs, including 51 hypomethylated and 10 hypermethylated regions.
40164_2018_123_MOESM2_ESM.pdf (2.4 mb)
Additional file 2. Chromosomal locations of hypoDMRs overlapping with repeat elements. The type of repeat and family of repeats are noted.
40164_2018_123_MOESM3_ESM.xlsx (12 kb)
Additional file 3. A representative region of chromosome 6 showing the characteristic overlap of hypoDMRs with repeat elements.

References

  1. 1.
    Beerman I, Bock C, Garrison BS, Smith ZD, Gu H, Meissner A, et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 2013;12:413–25.  https://doi.org/10.1016/j.stem.2013.01.017.CrossRefPubMedGoogle Scholar
  2. 2.
    Dykstra B, Olthof S, Schreuder J, Ritsema M, de Haan G. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med. 2011;208:2691–703.  https://doi.org/10.1084/jem.20111490.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314:1937–44.  https://doi.org/10.1016/j.yexcr.2008.03.006.CrossRefPubMedGoogle Scholar
  4. 4.
    Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585–621.  https://doi.org/10.1016/0014-4827(61)90192-6.CrossRefPubMedGoogle Scholar
  5. 5.
    Campisi J, di Fagagna FA. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729–40.  https://doi.org/10.1038/nrm2233.CrossRefPubMedGoogle Scholar
  6. 6.
    Bhatia-Dey N, Kanherkar RR, Stair SE, Makarev EO, Csoka AB. Cellular senescence as the causal nexus of aging. Front Genet. 2016.  https://doi.org/10.3389/fgene.2016.00013.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005;37:961–76.  https://doi.org/10.1016/j.biocel.2004.10.013.CrossRefPubMedGoogle Scholar
  8. 8.
    García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016;529:37–42.  https://doi.org/10.1038/nature16187.CrossRefPubMedGoogle Scholar
  9. 9.
    Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008;134:657–67.  https://doi.org/10.1016/j.cell.2008.06.049.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Zhang Y, Herbert B-S, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, et al. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway. FASEB J. 2009;23:1358–65.  https://doi.org/10.1096/fj.08-110296.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mendelsohn AR, Larrick JW. Rejuvenating muscle stem cell function: restoring quiescence and overcoming senescence. Rejuvenation Res. 2016;19:182–6.  https://doi.org/10.1089/rej.2016.1829.CrossRefPubMedGoogle Scholar
  12. 12.
    Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2015;87:15–25.  https://doi.org/10.1016/j.freeradbiomed.2015.05.045.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Li T, Zhou Z-W, Ju Z, Wang Z-Q. DNA damage response in hematopoietic stem cell ageing. Genomics Proteomics Bioinformatics. 2016;14:147–54.  https://doi.org/10.1016/j.gpb.2016.04.002.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wang Y, Cen J, He J, Shen H, Liu D, Li Y, et al. Accelerated cellular senescence in myelodysplastic syndrome. Exp Hematol. 2009;37:1310–7.  https://doi.org/10.1016/j.exphem.2009.09.002.CrossRefPubMedGoogle Scholar
  15. 15.
    Chang J, Wang Y, Shao L, Laberge R-M, Demaria M, Campisi J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med. 2016;22:78–83.  https://doi.org/10.1038/nm.4010.CrossRefPubMedGoogle Scholar
  16. 16.
    Capone S, Connor KM, Colombo A, Li X, Triche TJ, Ramsingh G. Senescent human hematopoietic progenitors show elevated expression of transposable elements and inflammatory genes. Exp Hematol. 2018;62(33–38):e6.  https://doi.org/10.1016/j.exphem.2018.03.003.CrossRefGoogle Scholar
  17. 17.
    de Koning APJ, Gu W, Castoe TA, Batzer MA, Pollock DD. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011;7:e1002384.  https://doi.org/10.1371/journal.pgen.1002384.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    De Cecco M, Criscione SW, Peckham EJ, Hillenmeyer S, Hamm EA, Manivannan J, et al. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell. 2013;12:247–56.  https://doi.org/10.1111/acel.12047.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wood JG, Helfand SL. Chromatin structure and transposable elements in organismal aging. Front Genet. 2013.  https://doi.org/10.3389/fgene.2013.00274.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Colombo AR, Zubair A, Thiagarajan D, Nuzhdin S, Triche TJ, Ramsingh G. Suppression of transposable elements in leukemic stem cells. Sci Rep. 2017;7:7029.  https://doi.org/10.1038/s41598-017-07356-9.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell. 2015;162:974–86.  https://doi.org/10.1016/j.cell.2015.07.011.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 2015;162:961–73.  https://doi.org/10.1016/j.cell.2015.07.056.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Leonova KI, Brodsky L, Lipchick B, Pal M, Novototskaya L, Chenchik AA, et al. p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci. 2013;110:E89–98.  https://doi.org/10.1073/pnas.1216922110.CrossRefPubMedGoogle Scholar
  24. 24.
    Slotkin RK, Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat Rev Genet. 2007;8:272–85.  https://doi.org/10.1038/nrg2072.CrossRefPubMedGoogle Scholar
  25. 25.
    Xie M, Hong C, Zhang B, Lowdon RF, Xing X, Li D, et al. DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat Genet. 2013;45:836–41.  https://doi.org/10.1038/ng.2649.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Mukamel Z, Tanay A. Hypomethylation marks enhancers within transposable elements. Nat Genet. 2013;45:717–8.  https://doi.org/10.1038/ng.2680.CrossRefPubMedGoogle Scholar
  27. 27.
    Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer. 2009;124:81–7.  https://doi.org/10.1002/ijc.23849.CrossRefPubMedGoogle Scholar
  28. 28.
    Hur K, Cejas P, Feliu J, Moreno-Rubio J, Burgos E, Boland CR, et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut. 2014;63:635–46.  https://doi.org/10.1136/gutjnl-2012-304219.CrossRefPubMedGoogle Scholar
  29. 29.
    Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4:1798–806.  https://doi.org/10.1038/nprot.2009.191.CrossRefPubMedGoogle Scholar
  30. 30.
    Coetzee SG, Coetzee GA, Hazelett DJ. motifbreakR : an R/Bioconductor package for predicting variant effects at transcription factor binding sites: Fig. 1. Bioinformatics. 2015; btv470.  https://doi.org/10.1093/bioinformatics/btv470.
  31. 31.
  32. 32.
    Hastie T, Tibshirani R, Sherlock G. Imputing missing data for gene expression arrays. Stanford Univ Tech Rep. 1999.  https://doi.org/10.1007/978-3-642-33269-2.CrossRefGoogle Scholar
  33. 33.
    Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17:520–5.CrossRefGoogle Scholar
  34. 34.
    Fortin J-P, Hansen KD. Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Genome Biol. 2015;16:180.  https://doi.org/10.1186/s13059-015-0741-y.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Johnson B, Fortin J, Hansen K, Triche T. compartmap: A/B compartment inference from ATAC-seq and methylation array data. R package version 1.0.2. 2018. https://github.com/biobenkj/compartmap.
  36. 36.
    Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol. 2007;371:21–31.CrossRefGoogle Scholar
  37. 37.
    Sosińska P, Mikuła-Pietrasik J, Ryżek M, Naumowicz E, Książek K. Specificity of cytochemical and fluorescence methods of senescence-associated β-galactosidase detection for ageing driven by replication and time. Biogerontology. 2014;15:407–13.  https://doi.org/10.1007/s10522-014-9505-4.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Cruickshanks HA, McBryan T, Nelson DM, VanderKraats ND, Shah PP, van Tuyn J, et al. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol. 2013;15:1495–506.  https://doi.org/10.1038/ncb2879.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Sundaram V, Cheng Y, Ma Z, Li D, Xing X, Edge P, et al. Widespread contribution of transposable elements to the innovation of gene regulatory networks. Genome Res. 2014;24:1963–76.  https://doi.org/10.1101/gr.168872.113.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Cui F, Sirotin MV, Zhurkin VB. Impact of Alu repeats on the evolution of human p53 binding sites. Biol Direct. 2011;6:2.  https://doi.org/10.1186/1745-6150-6-2.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Schmidt D, Schwalie PC, Wilson MD, Ballester B, Gonçalves Â, Kutter C, et al. Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell. 2012;148:335–48.  https://doi.org/10.1016/j.cell.2011.11.058.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Wylie A, Jones AE, D’Brot A, Lu W-J, Kurtz P, Moran JV, et al. p53 genes function to restrain mobile elements. Genes Dev. 2016;30:64–77.  https://doi.org/10.1101/gad.266098.115.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Göransson M, Elias E, Ståhlberg A, Olofsson A, Andersson C, Åman P. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP β-mediated interleukin 6 expression. Int J Cancer. 2005;115:556–60.  https://doi.org/10.1002/ijc.20893.CrossRefPubMedGoogle Scholar
  44. 44.
    Mann IK, Chatterjee R, Zhao J, He X, Weirauch MT, Hughes TR, et al. CG methylated microarrays identify a novel methylated sequence bound by the CEBPB ATF4 heterodimer that is active in vivo. Genome Res. 2013;23:988–97.  https://doi.org/10.1101/gr.146654.112.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Khund Sayeed S, Zhao J, Sathyanarayana BK, Golla JP, Vinson C. C/EBPβ (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide. Biochim Biophys Acta Gene Regul Mech. 2015;1849:583–9.  https://doi.org/10.1016/j.bbagrm.2015.03.002.CrossRefGoogle Scholar
  46. 46.
    Guerrero A, Iglesias C, Raguz S, Floridia E, Gil J, Pombo CM, et al. The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell. 2015;14:274–83.  https://doi.org/10.1111/acel.12316.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017;356:eaaj2239.  https://doi.org/10.1126/science.aaj2239.CrossRefPubMedGoogle Scholar
  48. 48.
    Wood H. Human endogenous retrovirus-K activation is implicated in amyotrophic lateral sclerosis. Nat Rev Neurol. 2015;11:666.  https://doi.org/10.1038/nrneurol.2015.206.CrossRefPubMedGoogle Scholar
  49. 49.
    Li W, Lee M-H, Henderson L, Tyagi R, Bachani M, Steiner J, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7:307ra153.  https://doi.org/10.1126/scitranslmed.aac8201.CrossRefPubMedGoogle Scholar
  50. 50.
    Brown RH, Al-Chalabi A. Endogenous retroviruses in ALS: a reawakening? Sci Transl Med. 2015;7:307fs40.  https://doi.org/10.1126/scitranslmed.aad3533.CrossRefPubMedGoogle Scholar
  51. 51.
    Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, et al. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients—a twelve month follow-up. J Neuroimmunol. 2015;285:68–70.  https://doi.org/10.1016/j.jneuroim.2015.05.019.CrossRefPubMedGoogle Scholar
  52. 52.
    Duperray A, Barbe D, Raguenez G, Weksler BB, Romero IA, Couraud P-O, et al. Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4. Int Immunol. 2015;27:545–53.  https://doi.org/10.1093/intimm/dxv025.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Nexø BA, Jensen SB, Hansen B, Laska MJ. Endogenous retroviruses are associated with autoimmune diseases. Ugeskr Laeger. 2016;178:55–63.  https://doi.org/10.1007/s12026-015-8671-z.CrossRefGoogle Scholar
  54. 54.
    Trela M, Nelson PN, Rylance PB. The role of molecular mimicry and other factors in the association of Human Endogenous Retroviruses and autoimmunity. APMIS. 2016;124:88–104.  https://doi.org/10.1111/apm.12487.CrossRefPubMedGoogle Scholar
  55. 55.
    Burns KH. Transposable elements in cancer. Nat Rev Cancer. 2017;17:415–24.  https://doi.org/10.1038/nrc.2017.35.CrossRefPubMedGoogle Scholar
  56. 56.
    Balestrieri E, Pica F, Matteucci C, Zenobi R, Sorrentino R, Argaw-Denboba A, et al. Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells. Biomed Res Int. 2015;2015:1–9.  https://doi.org/10.1155/2015/164529.CrossRefGoogle Scholar
  57. 57.
    Lee Y-J, Jeong B-H, Choi E-K, Carp RI, Kim Y-S. Complete genome sequences of new xenotropic murine leukemia viruses from the senescence-accelerated mouse (SAM): molecular and phylogenetic analyses. PLoS ONE. 2013;8:e55669.  https://doi.org/10.1371/journal.pone.0055669.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Laderoute MP. A new paradigm about HERV-K102 particle production and blocked release to explain cortisol mediated immunosenescence and age-associated risk of chronic disease. Discov Med. 2015;20:379–91.PubMedGoogle Scholar

Copyright information

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Jane Anne Nohl Division of Hematology and Center for the Study of Blood DiseasesKeck School of Medicine of University of Southern CaliforniaLos AngelesUSA
  2. 2.Center for EpigeneticsVan Andel Research InstituteGrand RapidsUSA

Personalised recommendations